Andrew Watson, Vice President of AI and R & D at Healx – Interview Series

Andrew Watson is Vice President of AI and R & D at Healx. Prior to joining Healx he worked at the technology giant Dyson, where he was the founding member of the Machine Learning Research Department, leading the research and implementation of machine learning and artificial intelligence across a variety of global product categories. In his time as Director of Machine Learning at Dyson, Andrew also established a new research group, focused on the intersection between machine learning and cutting-edge biomedical research. Healx is an AI-powered, patient-inspired technology company, dedicated to helping rare disease patients around the world access life-improving therapies. There are 7,000 known rare diseases that affect 400 million people across the globe but only 5% of those conditions have approved treatments.